Masaharu Nishikido

Annual dialysis data report 2023, Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry

Takao Masaki, Norio Hanafusa, Masanori Abe, Nobuhiko Joki et autres

Abstract The annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was conducted with 4529 dialysis facilities at the end of 2023, of which 4470 facilities (98.7%) responded to the facility survey and 4284 facilities (94.6%) responded to …

jp (code pays fourni par la source)

Annual dialysis data report 2021, Japanese Society for Dialysis Therapy (JSDT) renal data registry

Norio Hanafusa, Masanori Abe, Nobuhiko Joki, Junichi Hoshino et autres

Abstract The annual survey of the Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry (JRDR) at the end of 2021 was conducted at 4508 facilities, of which 4454 facilities (98.8%) returned the facility questionnaire and 4251 (94.3%) returned the patient questionnaire, …

jp (code pays fourni par la source)

Annual dialysis data report 2020, JSDT renal data registry

Norio Hanafusa, Masanori Abe, Nobuhiko Joki, Junichi Hoshino et autres

Abstract Background The 2020 Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) annual survey was sent to 4493 dialysis facilities in Japan. Methods Questionnaires were sent to all facilities that provide patients with dialysis therapy in Japan. Data were collected and …

jp (code pays fourni par la source)

[A Retrospective Study on the Malignancies after Renal Transplantation].

Tsuyoshi Matsuda, Yasushi Mochizuki, Yuta Mukae, Hiromi Nakanishi et autres

Detection of post-transplant malignant tumors and the analysis of the associated risk factors is important for monitoring the progress after renal transplantation. In this study, we retrospectively examined the medical records of 298 patients who underwent renal transplantation at two facilities in …

jp (code pays fourni par la source)

Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non‐muscle‐invasive bladder cancer: a randomised clinical trial

Yasuyoshi Miyata, Toshifumi Tsurusaki, Yasushi Hayashida, Yushi Imasato et autres

OBJECTIVES: To compare the urinary pH, recurrence-free survival (RFS), and safety of adjuvant intravesical therapy in patients with non-muscle-invasive bladder cancer (NMIBC) receiving mitomycin C (MMC) therapy and MMC + cytosine arabinoside (Ara-C) therapy. PATIENTS AND METHODS: A total of 165 patients …

jp (code pays fourni par la source)

A case of early recurrent immunoglobulin A nephropathy and T-cell-mediated rejection in a transplant patient with Wiskott–Aldrich syndrome

K Yamaguchi, Mineaki Kitamura, Yuki Kawaguchi, Kanako Hayashi et autres

jp (code pays fourni par la source)

Annual dialysis data report of the 2018 JSDT Renal Data Registry: dementia, performance status, and exercise habits

Kosaku Nitta, Shigeru Nakai, Ikuto Masakane, Norio Hanafusa et autres

Abstract According to the annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) conducted at the end of 2018, there were a total of 339,841 patients receiving dialysis (hereinafter, dialysis patients) in Japan. The survey included questions regarding …

jp (code pays fourni par la source)

A randomized clinical trial of intravesical instillation of MMC and combination of MMC and Ara-C in non-muscle invasive bladder cancer

Yuki Miyata, T. Matsuo, Kojiro Ohba, Kensuke Mitsunari et autres

Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality

Kosaku Nitta, Shunsuke Goto, Ikuto Masakane, Norio Hanafusa et autres

Abstract The annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was sent to 4458 dialysis facilities at the end of 2018; among these facilities, 4402 facilities (98.7%) responded to the facility questionnaire, and 4222 (94.7%) responded to …

jp (code pays fourni par la source)

Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis

Mineaki Kitamura, Yohei Tateishi, Shuntaro Sato, Satoko Kitamura et autres

BACKGROUND: High serum calcium levels should be avoided in patients on hemodialysis (HD) because they can induce cardiovascular diseases and worsen the patient's prognosis. In contrast, low serum calcium levels worsen the prognosis of patients with cerebral hemorrhage in the general population. …

jp (code pays fourni par la source)

Prediction of Nonadherence and Renal Prognosis by Pre-Transplantation Serum Phosphate Levels

Mineaki Kitamura, Yasushi Mochizuki, Satoko Kitamura, Yuta Mukae et autres

BACKGROUND Identifying characteristics of patients at high risk of poor adherence before transplantation would be advantageous. However, the optimal approach for characterizing such patients remains unknown. We aimed to evaluate the association between factors for hemodialysis nonadherence and post-transplant renal prognosis. We …

jp (code pays fourni par la source)

Methotrexate-induced acute kidney injury in patients with hematological malignancies: three case reports with literature review

Mineaki Kitamura, Satoko Kitamura, Machiko Fujioka, Rena Kamijo et autres

High-dose methotrexate (HD-MTX) therapy has been used to treat a wide range of oncological malignancies. While the therapy can be tolerated with hydration, urine pH control, and leucovorin rescue therapy, HD-MTX is cytotoxic and can cause renal failure. There have been several …

jp (code pays fourni par la source)